Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This is an open Label, randomized, two-period, two-treatment, two-sequence, crossover,
balanced, single dose pivotal study. The purpose of this study is to assess the
bioequivalence between Test Product and the corresponding Reference Product under fasting
condition in healthy adult human subjects.